AstraZeneca will acquire Alexion Pharmaceuticals in $39 billion push into rare diseases and immunology
December 14, 2020EditorTrading IdeasComments Off on AstraZeneca will acquire Alexion Pharmaceuticals in $39 billion push into rare diseases and immunology